Hepatitis C

Hepatitis C is a blood-borne virus that infects the liver, where it causes significant inflammation, damage and disruption of normal liver function. According to estimates by the World Health Organization, around 3 to 4 million people worldwide are infected with hepatitis C every year.
What is Hepatitis C?

Hepatitis C infection is a liver infection caused by the Hepatitis C virus. Infection with hepatitis C may damage the liver leading to chronic infection.

Read More

Overview

Feature Articles

Latest Hepatitis C News and Research

Study highlights the urgent need for combinatorial drug therapies for SARS-CoV-2

Study highlights the urgent need for combinatorial drug therapies for SARS-CoV-2

New CDC Vital Signs report: Few people diagnosed with hepatitis C receive timely treatment

New CDC Vital Signs report: Few people diagnosed with hepatitis C receive timely treatment

New CDC Vital Signs report: Less than a third of people diagnosed with hepatitis C get timely treatment

New CDC Vital Signs report: Less than a third of people diagnosed with hepatitis C get timely treatment

Inexpensive, self-driven microfluidic chip rapidly detects Hepatitis C virus in about 45 minutes

Inexpensive, self-driven microfluidic chip rapidly detects Hepatitis C virus in about 45 minutes

International travel restrictions were a key intervention for slowing COVID-19 spread, study shows

International travel restrictions were a key intervention for slowing COVID-19 spread, study shows

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

Combinations of broadly neutralizing antibodies may be a more effective approach to treat HIV

Combinations of broadly neutralizing antibodies may be a more effective approach to treat HIV

The known and proposed interactions of SARS-CoV and SARS-CoV-2 with DNA damage response pathways

The known and proposed interactions of SARS-CoV and SARS-CoV-2 with DNA damage response pathways

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

Investigating the prerequisites for developing RNA-based antibiotics

Investigating the prerequisites for developing RNA-based antibiotics

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Study shows alarming trends in mortality from alcoholic cirrhosis in the U.S.

Study shows alarming trends in mortality from alcoholic cirrhosis in the U.S.

As Biden fights overdoses, harm reduction groups face local opposition

As Biden fights overdoses, harm reduction groups face local opposition

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Study explores the substrate selectivity of the SARS-CoV-2 replicase

Study explores the substrate selectivity of the SARS-CoV-2 replicase

Scientists examine the impact of herpesviruses on (pre)diabetes

Scientists examine the impact of herpesviruses on (pre)diabetes

Perceived stigmatization is common among patients with NAFLD, study finds

Perceived stigmatization is common among patients with NAFLD, study finds

Potential indirect and direct effects of SARS-CoV-2 on pancreatic islets in patients who became hyperglycemic after COVID-19

Potential indirect and direct effects of SARS-CoV-2 on pancreatic islets in patients who became hyperglycemic after COVID-19

Artificial circular RNAs found to bypass cellular antiviral responses

Artificial circular RNAs found to bypass cellular antiviral responses

CDC issues health alert about children identified with hepatitis and adenovirus infection

CDC issues health alert about children identified with hepatitis and adenovirus infection